Interactions between the heart and kidneys have been labeled as the cardiorenal syndrome (CRS). Type-5 CRS describes a disease that simultaneously damages both organs. With severe infection, systemic inflammatory mediators (TNF-α and IL-1β) cause wide-spread endothelial dysfunction, cellular apoptosis, and depressed organ function. Impaired myocardial function promotes worsening renal function and vice versa, leading to a dangerous positive feedback loop. Influenza viruses cause both myocardial and kidney injury, presumably through an immune-mediated mechanism. Herein we present a lethal case of influenza, resulting in acute type V cardiorenal syndrome.

Keywords:
Type 5 cardiorenal syndrome, Influenza, Myocarditis
1.
Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
2.
Ronco C, McCullough PA, Anker SD, Anad I, et al, Acute Dialysis Quality Initiative (ADQI) Consensus Group: Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. Basel, Karger, 2010, vol 165, pp 54-67.
3.
Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Aucte renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002;168:5817-5823.
4.
Kumar A, Paladugu B, Mening J, Kumar A, Parrillo JE. Nitric oxide-dependent and oxide-independent mechanisms are involved in TNF-alpha-induced depression of cardiac myocyte contractility. Am J Physiol Regul Integr Comp Physiol 2007;292:R1900-R1906.
5.
Kumar A, Brar R, Wang P, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996;183:949-958.
6.
Takasu O, Gaut JP, Watanabe E, To K, et al: Mechanisims of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 2013;187:509-517.
7.
Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients wiht sepsis, shoc, and multiple organ dysfunction. Crit Care Med 1999;27:1230-1251.
8.
Rudiger A, Singer M: Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007;35:1599-1608.
9.
Murugan R, Kellum JA: Acute kidney injury: what's the prognosis? Nat Rev Nephrol 2011;7:209-217.
10.
Schnitzler SU, Schnitzler P: An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009;39:279-292.
11.
Kaiser L, Fritz RS, Straus Se, et al: Symptom pathogenesis during acute influenza; interleukin-6 and other cytokine responses. J Med Virol 2001;64:262-268.
12.
Takano T, Tajiri H, Kashiwagi Y, et al: Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2011;30:117-120.
13.
Onitsuka H, Imamura T, Miyamoto N: Clinical manifestations of influenza myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol 2001;37:315-323.
14.
Ison MG, Campbell V, Rembold C, et al: Cardiac findings during uncomplicated acute influenza in ambulatory adults. Clin Infect Dis 2005;40:415-422.
15.
Nin N, Lorente JA, Soto L, et al: Acute kidney injury in critically ill patients with 2009 influenza A (H1N1) viral pneumonia: an observation study. Intens Care Med 2011;37:768.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.